Reilly, M., Miller, R. M., Thomson, M. H., Patris, V., Ryle, P., McLoughlin, L., . . . Wetering de Rooij, J. (2013). Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalating Phase I, Healthy Subjects Study of Intravenous OPN‐305, a Humanized Anti‐TLR2 Antibody. Clinical pharmacology and therapeutics, 94(5), 593-600. https://doi.org/10.1038/clpt.2013.150
Chicago-Zitierstil (17. Ausg.)Reilly, M., et al. "Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalating Phase I, Healthy Subjects Study of Intravenous OPN‐305, a Humanized Anti‐TLR2 Antibody." Clinical Pharmacology and Therapeutics 94, no. 5 (2013): 593-600. https://doi.org/10.1038/clpt.2013.150.
MLA-Zitierstil (9. Ausg.)Reilly, M., et al. "Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalating Phase I, Healthy Subjects Study of Intravenous OPN‐305, a Humanized Anti‐TLR2 Antibody." Clinical Pharmacology and Therapeutics, vol. 94, no. 5, 2013, pp. 593-600, https://doi.org/10.1038/clpt.2013.150.